Analyze Diet

Topic:Disease Prevention

Disease prevention in horses encompasses strategies and practices aimed at minimizing the occurrence and spread of infectious and non-infectious diseases within equine populations. These practices include vaccination programs, biosecurity measures, and regular health monitoring. Vaccination helps to stimulate the horse's immune system to protect against specific pathogens, while biosecurity measures, such as quarantine and sanitation, reduce the risk of disease transmission. Regular health monitoring, including physical examinations and diagnostic testing, aids in early detection and management of potential health issues. This page compiles peer-reviewed research studies and scholarly articles that explore various methods and their effectiveness in preventing diseases in horses, as well as the development and implementation of prevention programs in different equine settings.
The diagnosis of equine insulin dysregulation.
Equine veterinary journal    June 23, 2017   Volume 49, Issue 5 570-576 doi: 10.1111/evj.12703
Bertin FR, de Laat MA.Insulin dysregulation is the hallmark of equine metabolic syndrome and has received attention because of its direct association with laminitis. In the absence of an adequate treatment for laminitis, a focus on prophylaxis is needed, making early detection of individuals at risk of developing laminitis one of the main challenges in equine endocrinology. Recent studies have shown that insulin dysregulation goes beyond tissue insulin resistance and it is now demonstrated that the equine enteroinsular axis plays a major role in insulin secretion and equine hyperinsulinaemia. In this review, we dis...
Playing with fire – What is influencing horse owners’ decisions to not vaccinate their horses against deadly Hendra virus infection?
PloS one    June 21, 2017   Volume 12, Issue 6 e0180062 doi: 10.1371/journal.pone.0180062
Goyen KA, Wright JD, Cunneen A, Henning J.Hendra virus is a zoonotic paramyxovirus, which causes severe respiratory and neurological disease in horses and humans. Since 2012, the Hendra virus sub-unit G vaccine has been available for horse vaccination in Australia. Uptake of the vaccine has been limited and spill-over events of Hendra virus infection in horses continue to occur. We conducted an online, questionnaire-based cross-sectional study of 376 horse owners belonging to a variety of different equestrian clubs in Queensland, Australia, to identify risk factors for non-vaccination against Hendra virus. A total of 43.1% (N = 162) o...
Type-specific L1 virus-like particle-mediated protection of horses from experimental bovine papillomavirus 1-induced pseudo-sarcoid formation is long-lasting.
The Journal of general virology    June 21, 2017   Volume 98, Issue 6 1329-1333 doi: 10.1099/jgv.0.000791
Harnacker J, Hainisch EK, Shafti-Keramat S, Kirnbauer R, Brandt S.Equine sarcoids are common therapy-resistant skin tumours induced by bovine papillomavirus type 1 or 2 (BPV1, BPV2) infection. We have previously shown that prophylactic vaccination with BPV1 L1 virus-like particles (VLPs) efficiently protects horses from experimental BPV1-induced pseudo-sarcoid development. Here, we assessed BPV1 L1 VLP vaccine-mediated long-term protection from experimental tumour formation in seven horses 5 years after immunization with three different doses of BPV1 L1 VLPs, and three unvaccinated control animals. Horses were challenged by intradermal inoculation with infec...
Interlaboratory trial for the measurement of total cobalt in equine urine and plasma by ICP-MS.
Drug testing and analysis    June 20, 2017   Volume 9, Issue 9 1400-1406 doi: 10.1002/dta.2191
Popot MA, Ho ENM, Stojiljkovic N, Bagilet F, Remy P, Maciejewski P, Loup B, Chan GHM, Hargrave S, Arthur RM, Russo C, White J, Hincks P, Pearce C....Cobalt is an essential mineral micronutrient and is regularly present in equine nutritional and feed supplements. Therefore, cobalt is naturally present at low concentrations in biological samples. The administration of cobalt chloride is considered to be blood doping and is thus prohibited. To control the misuse of cobalt, it was mandatory to establish an international threshold for cobalt in plasma and/or in urine. To achieve this goal, an international collaboration, consisting of an interlaboratory comparison between 5 laboratories for the urine study and 8 laboratories for the plasma stud...
Equine atypical myopathy in the UK: Epidemiological characteristics of cases reported from 2011 to 2015 and factors associated with survival.
Equine veterinary journal    June 19, 2017   Volume 49, Issue 6 746-752 doi: 10.1111/evj.12694
González-Medina S, Ireland JL, Piercy RJ, Newton JR, Votion DM.Equine atypical myopathy (AM) is a toxic rhabdomyolysis associated with ingestion of hypoglycin A, derived typically in Europe, from Acer pseudoplatanus tree. Despite the wide distribution of this tree species in the UK, the number of cases reported annually varies, and there has been an apparent increase in prevalence in recent years. Although AM was first recognised in the UK, epidemiological studies have never been conducted focused solely on this country. Objective: To describe the spatiotemporal distribution, presentation, treatment and outcome of AM cases reported in the UK. Methods: Ret...
Control of lice infestation in horses using a 10 mg/mL deltamethrin topical application.
Irish veterinary journal    June 19, 2017   Volume 70 22 doi: 10.1186/s13620-017-0100-2
Castilla-Castaño E, Vischi A, Navarro C, Lecru LA, Ribeiro C, Pradier S, Cadiergues MC.Two open-controlled studies evaluated the tolerance and the efficacy of a 10 mg/mL deltamethrin-based pour-on solution (Deltanil®; Virbac, France) in treating (study 1) and preventing (study 2) natural Damalinia equi infestations in horses. In study 1, seven adult horses received 10 mL of the solution from mane to tail head on day 0 (D0). Four adult horses, living separately, served as non-treated controls. All were naturally infected. Lice burden was recorded by counting the number of live parasites, bilaterally, over seven anatomic regions. Lesional score was based on alopecia, crusts, papu...
Science-in-brief: Bisphosphonate use in the racehorse: Safe or unsafe?
Equine veterinary journal    June 13, 2017   Volume 49, Issue 4 404-407 doi: 10.1111/evj.12682
McLellan J.No abstract available
Erratum to: Arrhythmogenic right ventricular cardiomyopathy secondary to adipose infiltration as a cause of episodic collapse in a horse.
Irish veterinary journal    June 7, 2017   Volume 70 19 doi: 10.1186/s13620-017-0099-4
Raftery AG, Cuesta-Garcia N, Thompson H, Sutton DGM.[This corrects the article DOI: 10.1186/s13620-015-0052-3.].
Disseminated Cryptococcus deuterogattii (AFLP6/VGII) infection in an Arabian horse from Dubai, United Arab Emirates.
Revista iberoamericana de micologia    June 7, 2017   Volume 34, Issue 4 229-232 doi: 10.1016/j.riam.2017.02.007
Kinne J, Joseph M, Wernery U, Nogradi N, Hagen F.During the past decades there has been an increase in cryptococcal infections caused by the basidiomycetous yeast species Cryptococcus gattii sensu lato, among humans and animals that live in endemic regions in Australia, Europe and the Americas. Unlike human cryptococcosis, little epidemiological data are available about C. gattii sensu lato infections in horses. Methods: A fatal case of a disseminated C. gattii sensu lato infection in an 11-year-old Arabian gelding imported from South Africa into the United Arab Emitares is reported. Tissue samples were studied by conventional mycology proce...
A new equine and zoonotic threat emerges from an old avian pathogen, Chlamydia psittaci. Polkinghorne A, Greub G.No abstract available
Equine performance genes and the future of doping in horseracing.
Drug testing and analysis    May 30, 2017   Volume 9, Issue 9 1456-1471 doi: 10.1002/dta.2198
Wilkin T, Baoutina A, Hamilton N.A horse's success on the racetrack is determined by genetics, training and nutrition, and their translation into physical traits such as speed, endurance and muscle strength. Advances in genetic technologies are slowly explaining the roles of specific genes in equine performance, and offering new insights into the development of novel therapies for diseases and musculoskeletal injuries that cause early retirement of many racehorses. Gene therapy approaches may also soon provide new means to artificially enhance the physical performance of racehorses. Gene doping, the misuse of gene therapies f...
Effects of feeding two RRR-α-tocopherol formulations on serum, cerebrospinal fluid and muscle α-tocopherol concentrations in horses with subclinical vitamin E deficiency.
Equine veterinary journal    May 25, 2017   Volume 49, Issue 6 753-758 doi: 10.1111/evj.12692
Brown JC, Valberg SJ, Hogg M, Finno CJ.Alpha-tocopherol (α-TP) supplementation is recommended for the prevention of various equine neuromuscular disorders. Formulations available include RRR-α-TP acetate powder and a more expensive but rapidly water-dispersible liquid RRR-α-TP (WD RRR-α-TP). No cost-effective means of rapidly increasing serum and cerebrospinal fluid (CSF) α-TP with WD RRR-α-TP and then sustaining concentrations with RRR-α-TP acetate has yet been reported. Objective: To evaluate serum, CSF and muscle α-TP concentrations in an 8-week dosing regimen in which horses were transitioned from WD RRR-α-TP to RRR-α...
[New drugs for horses and production animals in 2016].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    May 17, 2017   Volume 45, Issue 3 176-181 doi: 10.15653/TPG-170267
Emmerich IU.In 2016, only one newly developed active pharmaceutical ingredient for horses and food-producing animals was released on the German market for veterinary drug products. The immunomodulator Pegbovigrastim is now available as an injection solution for cattle (Imrestor). Four established veterinary active pharmaceutical ingredients are available for further species: the ectoparasitic Amitraz (Apitraz) from the triazapentadiene group was additionally authorized for honeybees, the expectorant Bromhexine (Exflow Vet) for chickens, turkeys and ducks and the macrolide antibiotic Gamithromycin (Zactran...
Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.
PloS one    May 16, 2017   Volume 12, Issue 5 e0177831 doi: 10.1371/journal.pone.0177831
Tallmadge RL, Miller SC, Parry SA, Felippe MJB.The value of prophylactic neonatal vaccination is challenged by the interference of passively transferred maternal antibodies and immune competence at birth. Taken our previous studies on equine B cell ontogeny, we hypothesized that the equine neonate generates a diverse immunoglobulin repertoire in response to vaccination, independently of circulating maternal antibodies. In this study, equine neonates were vaccinated with 3 doses of keyhole limpet hemocyanin (KLH) or equine influenza vaccine, and humoral immune responses were assessed using antigen-specific serum antibodies and B cell Ig var...
Clinical Serum Therapy: Benefits, Cautions, and Potential Applications.
The Keio journal of medicine    April 28, 2017   Volume 66, Issue 4 57-64 doi: 10.2302/kjm.2016-0017-IR
Hifumi T, Yamamoto A, Ato M, Sawabe K, Morokuma K, Morine N, Kondo Y, Noda E, Sakai A, Takahashi J, Umezawa K.Blood serum from immunized humans or animals (e.g., horses) contains relevant antibodies and has been used as serum therapy to treat many diseases or envenomation events. The effectiveness of blood serum was initially discovered in 1890 when Kitasato and von Behring observed the effectiveness of this type of therapy against diphtheria and tetanus. Serum therapies played an important role in the advancement of modern medicine prior to the development of penicillin and steroids. At present, several types of serum therapy remain in clinical use. However, some physicians have a limited understandi...
Intelligence-based anti-doping from an equine biological passport.
Drug testing and analysis    April 17, 2017   Volume 9, Issue 9 1441-1447 doi: 10.1002/dta.2180
Cawley AT, Keledjian J.The move towards personalized medicine derived from individually focused clinical chemistry measurements has been translated by the human anti-doping movement over the past decade into developing the athlete biological passport. There is considerable potential for animal sports to adapt this model to facilitate an intelligence-based anti-doping system. Copyright © 2017 John Wiley & Sons, Ltd.
Vet students help regiments declare their horses to be ‘strangles free’.
The Veterinary record    April 15, 2017   Volume 180, Issue 15 373 doi: 10.1136/vr.j1816
No abstract available
“Why won’t they just vaccinate?” Horse owner risk perception and uptake of the Hendra virus vaccine.
BMC veterinary research    April 13, 2017   Volume 13, Issue 1 103 doi: 10.1186/s12917-017-1006-7
Manyweathers J, Field H, Longnecker N, Agho K, Smith C, Taylor M.Hendra virus is a paramyxovirus that causes periodic serious disease and fatalities in horses and humans in Australia first identified in 1994. Pteropid bats (commonly known as flying-foxes) are the natural host of the virus, and the putative route of infection in horses is by ingestion or inhalation of material contaminated by flying-fox urine or other bodily fluids. Humans become infected after close contact with infected horses. Horse owners in Australia are encouraged to vaccinate their horses against Hendra virus to reduce the risk of Hendra virus infection, and to prevent potential trans...
Suspected aspirin resistance in individual healthy adult warmblood horses.
Journal of veterinary pharmacology and therapeutics    April 7, 2017   Volume 40, Issue 6 e16-e22 doi: 10.1111/jvp.12408
Roscher KA, Failing K, Schenk I, Moritz A.The reasons for this prospective experimental study were to determine a dosing scheme with loading and maintenance dose of aspirin inducing inhibition of platelet function measured by whole blood impedance aggregometry. Ten horses received aspirin orally in the morning with one loading dose of 4.7-5 mg/kg and maintenance doses of 1-1.3 mg/kg daily the following 4 days. Aggregometries (COLtest, ASPItest, ADPtest) and serum salicylic acid were measured. ASPItest showed significant difference in inhibition at 24 and 48 hr (p < .05) and 96 hr (p < .01). Significant change for ADPtes...
Managing anthelmintic resistance in Parascaris spp.: A modelling exercise.
Veterinary parasitology    March 30, 2017   Volume 240 75-81 doi: 10.1016/j.vetpar.2017.03.026
Leathwick DM, Sauermann CW, Geurden T, Nielsen MK.A previously described model for the dynamics of the parasitic stages of Parascaris spp. was modified to include eggs outside the host and the genetics of anthelmintic resistance before being used to address questions regarding the development of resistance. Three broad questions were addressed; i) How sustainable is the current common practice of treating foals monthly for their first year of life (i.e. 12 treatments/year)? ii) Does the timing of treatments have an effect on resistance development? (i.e. do certain treatments select for resistance more strongly than others?), and iii) How sus...
Carbapenemase-Producing Aeromonas veronii Disseminated in the Environment of an Equine Specialty Hospital.
Vector borne and zoonotic diseases (Larchmont, N.Y.)    March 27, 2017   Volume 17, Issue 6 439-442 doi: 10.1089/vbz.2016.2083
Adams RJ, Mathys DA, Mollenkopf DF, Whittle A, Daniels JB, Wittum TE.The emergence of bacterial resistance to carbapenem antibiotics is an urgent public health threat. Carbapenem drugs are a last resort treatment option for life-threatening infections. The frequent use of broad-spectrum antibiotics to treat hospitalized patients provides significant selection pressure favoring the emergence and dissemination of resistant organisms, including carbapenem-resistant Enterobacteriaceae (CRE). CREs have been reported in animal populations, but only rarely in horses. Our objective was to determine the prevalence of CRE in the environment of a referral equine specialty...
Compounding of Veterinary Drugs for Equine Practitioners.
The Veterinary clinics of North America. Equine practice    March 23, 2017   Volume 33, Issue 1 213-225 doi: 10.1016/j.cveq.2016.12.003
Stanley SD, Moffitt K, Wiebe V.Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.
Equine Pharmacology.
The Veterinary clinics of North America. Equine practice    March 23, 2017   Volume 33, Issue 1 xi doi: 10.1016/j.cveq.2017.01.001
Magdesian KG.No abstract available
A survey of macrocyclic lactone efficacy in Australian cyathostomin populations.
Veterinary parasitology, regional studies and reports    March 21, 2017   Volume 8 127-132 doi: 10.1016/j.vprsr.2017.03.009
Beasley AM, Kotze AC, Allen K, Coleman GT.The macrocyclic lactone (ML) drugs are central to the control of equine strongyles but recent international reports raise concerns about reduced efficacy of these drugs against cyathostomins. The objectives of the present study were firstly, to evaluate the efficacy of ML drugs against cyathostomins on a cross-section of Australian horse farms, and secondly, to determine the egg reappearance period (ERP) following treatment of horses with MLs. A total of 419 horses on 43 properties were treated orally with ivermectin, abamectin or moxidectin, at recommended dose rates and drug efficacy was det...
What Is Your Diagnosis?
Journal of the American Veterinary Medical Association    March 18, 2017   Volume 250, Issue 7 751-753 doi: 10.2460/javma.250.7.751
Cha ML, Mochal-King C, Gambino J.No abstract available
Potential of a BPV1 L1 VLP vaccine to prevent BPV1- or BPV2-induced pseudo-sarcoid formation and safety and immunogenicity of EcPV2 L1 VLPs in horse.
The Journal of general virology    March 13, 2017   Volume 98, Issue 2 230-241 doi: 10.1099/jgv.0.000673
Hainisch EK, Abel-Reichwald H, Shafti-Keramat S, Pratscher B, Corteggio A, Borzacchiello G, Wetzig M, Jindra C, Tichy A, Kirnbauer R, Brandt S.We have previously shown that immunization of horses with bovine papillomavirus type 1 (BPV1) L1 virus-like particles (VLPs) is safe and highly immunogenic and that BPV1 and bovine papillomavirus type 2 (BPV2) are closely related serotypes. Here we evaluated the protective potential of a BPV1 L1 VLP vaccine against experimental BPV1 and BPV2 challenge and studied the safety and immunogenicity of a bivalent equine papillomavirus type 2 (EcPV2)/BPV1 L1 VLP vaccine. Fourteen healthy horses were immunized with BPV1 L1 VLPs (100 µg per injection) plus adjuvant on days 0 and 28, while seven remai...
“We’ve learned to live with it”-A qualitative study of Australian horse owners’ attitudes, perceptions and practices in response to Hendra virus.
Preventive veterinary medicine    March 12, 2017   Volume 140 67-77 doi: 10.1016/j.prevetmed.2017.03.003
Wiethoelter AK, Sawford K, Schembri N, Taylor MR, Dhand NK, Moloney B, Wright T, Kung N, Field HE, Toribio JLML.Hendra virus causes sporadic zoonotic disease in Australia following spill over from flying foxes to horses and from horses to people. Prevention and risk mitigation strategies such as vaccination of horses or biosecurity and property management measures are widely publicised, but hinge on initiative and action taken by horse owners as they mediate management, care and treatment of their animals. Hence, underlying beliefs, values and attitudes of horse owners influence their uptake of recommended risk mitigation measures. We used a qualitative approach to investigate attitudes, perceptions and...
Highlights of recent clinically relevant papers.
Equine veterinary education    March 5, 2017   Volume 29, Issue 4 178-179 doi: 10.1111/eve.12743
Wright S.No abstract available
An outbreak of psittacosis at a veterinary school demonstrating a novel source of infection.
One health (Amsterdam, Netherlands)    February 24, 2017   Volume 3 29-33 doi: 10.1016/j.onehlt.2017.02.003
Chan J, Doyle B, Branley J, Sheppeard V, Gabor M, Viney K, Quinn H, Janover O, McCready M, Heller J.In November 2014, New South Wales Health was notified of a cluster of respiratory illness in a veterinary school. Active case finding identified another case at a local equine stud. All cases had exposure to the equine fetal membranes of Mare A. This tissue subsequently tested positive for Chlamydia psittaci using quantitative real-time polymerase chain reaction. We conducted a cohort study of the university and stud farm staff to determine risk factors for disease. Nine people were exposed to the fetal membranes of Mare A. Of these, five cases of psittacosis were identified. Two required hosp...
Difficulties experienced by veterinarians when communicating about emerging zoonotic risks with animal owners: the case of Hendra virus.
BMC veterinary research    February 18, 2017   Volume 13, Issue 1 56 doi: 10.1186/s12917-017-0970-2
Mendez DH, Büttner P, Kelly J, Nowak M, Speare Posthumously R.Communication skills are essential for veterinarians who need to discuss animal health related matters with their clients. When dealing with an emerging zoonosis, such as Hendra virus (HeV), veterinarians also have a legal responsibility to inform their clients about the associated risks to human health. Here we report on part of a mixed methods study that examined the preparedness of, and difficulties experienced by, veterinarians communicating about HeV-related risks with their clients. Methods: Phase 1 was an exploratory, qualitative study that consisted of a series of face-to-face, semi-st...
1 33 34 35 36 37 119